ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 223 filers reported holding ZAI LAB LTD in Q3 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $109,000 | -19.3% | 4,500 | -7.3% | 0.00% | – |
Q2 2023 | $135,000 | +1587.5% | 4,852 | +1930.1% | 0.00% | – |
Q1 2023 | $8,000 | -57.9% | 239 | -62.2% | 0.00% | – |
Q4 2022 | $19,000 | +1800.0% | 632 | +1216.7% | 0.00% | – |
Q3 2022 | $1,000 | – | 48 | +860.0% | 0.00% | – |
Q2 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 5 | -96.2% | 0.00% | – |
Q4 2021 | $8,000 | +300.0% | 131 | +773.3% | 0.00% | – |
Q3 2021 | $2,000 | -99.9% | 15 | -99.9% | 0.00% | – |
Q2 2021 | $1,777,000 | +138.5% | 10,040 | +79.9% | 0.00% | – |
Q1 2021 | $745,000 | -25.0% | 5,580 | -24.0% | 0.00% | – |
Q4 2020 | $993,000 | +89.1% | 7,338 | +16.2% | 0.00% | – |
Q3 2020 | $525,000 | +5150.0% | 6,315 | +4952.0% | 0.00% | – |
Q2 2020 | $10,000 | -81.8% | 125 | -88.4% | 0.00% | – |
Q1 2020 | $55,000 | +5400.0% | 1,075 | +7578.6% | 0.00% | – |
Q4 2019 | $1,000 | -75.0% | 14 | -90.0% | 0.00% | – |
Q1 2019 | $4,000 | +300.0% | 140 | +185.7% | 0.00% | – |
Q3 2018 | $1,000 | – | 49 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |